Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
 

Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
(Reuters) - Amgen Inc and Belgium-based UCB SA said on Monday that their osteoporosis drug met all the primary endpoints by reducing the incidence of new vertebral fracture in postme**pausal women with osteoporosis in a late-stage study.


http://rc.feedsportal.com/r/24739227...19/rc/1/rc.img

http://rc.feedsportal.com/r/24739227...19/rc/2/rc.img

http://rc.feedsportal.com/r/24739227...19/rc/3/rc.img

http://da.feedsportal.com/r/24739227...5/sc/19/a2.img
http://adchoice.feedsportal.com/r/24.../sc/19/ach.imghttp://pi.feedsportal.com/r/24739227.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2473922...sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...U4:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...U4:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/aqIJfZNJ7RM